Evidence for anticipation and association of deletion size with severity in facioscapulohumerd muscular dystrophy
Rabi Tawil(Centre National de la Recherche Scientifique), Robert C. Griggs(University of Rochester), Michael McDermott(University of Leeds), Barbara Weiffenbach, Denise A. Figlewicz(Montreal General Hospital), Jerry R. Mendell(Nationwide Children's Hospital), James Forrester(University of Rochester), John T. Kissel(The Ohio State University Wexner Medical Center), Wendy King(The Ohio State University)
Cited by 210
Related Papers
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k
Evidence‐based path to newborn screening for duchenne muscular dystrophy
|Annals of Neurology|2012|816
Eteplirsen for the treatment of Duchenne muscular dystrophy
|Annals of Neurology|2013|793
Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinra
|Arthritis & Rheumatism|2004|743
Interleukin-1–Receptor Antagonist in the Muckle–Wells Syndrome
|New England Journal of Medicine|2003|655